Number of the records: 1  

Omecamtiv mecarbil activates ryanodine receptors from canine cardiac but not skeletal muscle

  1. TitleOmecamtiv mecarbil activates ryanodine receptors from canine cardiac but not skeletal muscle
    Author Nánási Jr. Péter
    Co-authors Gaburjáková Marta 1972- SAVMOFYZ ; SAVCEBIO - Ústav molekulárnej fyziológie a genetiky SAV    SCOPUS    ORCID

    Gaburjáková Jana 1972- SAVMOFYZ ; SAVCEBIO - Ústav molekulárnej fyziológie a genetiky SAV    SCOPUS    ORCID

    Almássy János

    Source document European Journal of Pharmacology. Vol. 809 (2017), p. 73–79
    Languageeng - English
    Document kindrozpis článkov z periodík (rbx)
    CitationsEL-OUMEIRI, Bachar - MC ENTEE, Kathleen - ANNONI, Filippo - HERPAIN, Antoine - EYNDEN, Frederic Vanden - JESPERS, Pascal - VAN NOOTEN, Guido - VAN DE BORNE, Philippe. Effects of the cardiac myosin activator Omecamtiv-mecarbil on severe chronic aortic regurgitation in Wistar rats. In BMC CARDIOVASCULAR DISORDERS. ISSN 1471-2261, 2018, vol. 18, no., pp.
    OBATA, Koji - MORITA, Hironobu - TAKAKI, Miyako. The energy-saving effect of a new myosin activator, omecamtiv mecarbil, on LV mechanoenergetics in rat hearts with blood-perfused isovolumic contraction model. In NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. ISSN 0028-1298, 2019, vol. 392, no. 9, pp. 1065-1070.
    KISLITSINA, Olga N. - RICH, Jonathan D. - WILCOX, Jane E. - PHAM, Duc T. - CHURYLA, Andrei - VOROVICH, Esther B. - GHAFOURIAN, Kambiz - YANCY, Clyde W. Shock Classification and Pathophysiological Principles of Therapeutics. In CURRENT CARDIOLOGY REVIEWS. ISSN 1573-403X, 2019, vol. 15, no. 2, pp. 102-113.
    FULOP, Gabor A. - OLAH, Attila - CSIPO, Tamas - KOVACS, Arpad - PORSZASZ, Robert - VERESS, Roland - HORVATH, Balazs - NAGY, Laszlo - BODI, Beata - FAGYAS, Miklos - HELGADOTTIR, Solveig Lind - BANHEGYI, Viktor - JUHASZ, Bela - BOMBICZ, Mariann - PRIKSZ, Daniel - NANASI, Peter - MERKELY, Bela - EDES, Istvan - CSANADI, Zoltan - PAPP, Zoltan - RADOVITS, Tamas - TOTH, Attila. Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans. In BASIC RESEARCH IN CARDIOLOGY. ISSN 0300-8428, 2021, vol. 116, no. 1, pp. Dostupné na: https://doi.org/10.1007/s00395-021-00866-8.
    LOOKIN, Oleg - KUZNETSOV, Daniil - PROTSENKO, Yuri. Omecamtiv mecarbil attenuates length-tension relationship in healthy rat myocardium and preserves it in monocrotaline-induced pulmonary heart failure. In CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. ISSN 0305-1870, 2022, vol. 49, no. 1, pp. 84-93. Dostupné na: https://doi.org/10.1111/1440-1681.13584.
    EL OUMEIRI, B. - DEWACHTER, L. - VAN DE BORNE, P. - HUBESCH, G. - MELOT, C. - JESPERS, P. - STEFANIDIS, C. - MC ENTEE, K. - VANDEN EYNDEN, F. Altered Left Ventricular Rat Gene Expression Induced by the Myosin Activator Omecamtiv Mecarbil. In GENES. JAN 2023, vol. 14, no. 1. Dostupné na: https://doi.org/10.3390/genes14010122.
    ZHOU, S.J. - LIU, Y. - HUANG, X.F. - WU, C.H. - PóRSZáSZ, R. Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future. In FRONTIERS IN CARDIOVASCULAR MEDICINE. ISSN 2297-055X, MAR 19 2024, vol. 11. Dostupné na: https://doi.org/10.3389/fcvm.2024.1337154.
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2017
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.1016/j.ejphar.2017.05.027
    article

    article

    File nameAccessSizeDownloadedTypeLicense
    Omecamtiv mecarbil activates ryanodine receptors from canine cardiac but not skeletal muscle.pdfNeprístupný/archív1.2 MB2Publisher's version
    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201720162.896Q21.090Q2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.